RxDoctor Payments Data

James Bendell

Reproductive Endocrinology · Lagrange, GANPI 1518071182

Payments from drug & device makers

What this record shows

This record is dominated by education: $17,043 of the $21,352 with a category attached, or 79.8%. Intuitive Surgical accounts for 87.4% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $9,704, more than ten times the $285 reported in 2019. Among reproductive endocrinology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,352in general payments, 2019–2025

Across 119 payments — averaging $179.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$19K
  • Boston Scientific$955
  • AbbVie$325
  • Axonics, Inc.$212
  • Mayne Pharma Commercial LLC$164
  • Therapeuticsmd, Inc.$151
  • plus $887 from 20 others

What the payments were for

  • Speaking & faculty fees$5002%
  • Travel & lodging$8974%
  • Food & beverage$2,91214%
  • Education$17,04380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,352 in reported general payments places this provider in the 95th percentile of 42 reproductive endocrinology providers in Georgia.

See all reproductive endocrinology providers in Georgia

Medicare billing

Part B allowed, 2024
$18,192
Medicare patients
64
Services billed
175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol119$3,291
Tolterodine Tartrate ErTolterodine Tartrate13$2,048
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$1,824
ValacyclovirValacyclovir Hcl17$1,410
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip57$1,233
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$528
Medroxyprogesterone Acetate34$505
Fluconazole49$373
Clobetasol Propionate14$353
Ibuprofen24$195
Levothyroxine Sodium15$120
Amitriptyline Hcl11$106
Ondansetron OdtOndansetron13$96
Azithromycin24$84
Oxycodone Hcl13$45

Paid to pharmacies, not to this prescriber.

Other reproductive endocrinology in Lagrange

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →